These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11789098)

  • 1. [Huntington disease--yet another mad protein?].
    Petersén A; Hansson O; Brundin P
    Lakartidningen; 2001 Dec; 98(50):5756-8, 5761. PubMed ID: 11789098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Huntington's disease: clinical and molecular genetics].
    Warita H; Shiro Y; Kashihara K; Abe K
    Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
    Hannan AJ
    Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Huntington's chorea: clinical aspects, genetics and current diagnosis].
    Spiegel R
    Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
    van Dellen A; Grote HE; Hannan AJ
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1007-19. PubMed ID: 16445565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
    Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.
    Jenkins BG; Andreassen OA; Dedeoglu A; Leavitt B; Hayden M; Borchelt D; Ross CA; Ferrante RJ; Beal MF
    J Neurochem; 2005 Oct; 95(2):553-62. PubMed ID: 16135087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: From molecular basis to therapeutic advances.
    Krobitsch S; Kazantsev AG
    Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Huntington disease. A review].
    Bonilla E
    Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The molecular bases of Huntington's disease: the role played by oxidative stress].
    Tasset I; Sánchez F; Túnez I
    Rev Neurol; 2009 Oct 16-31; 49(8):424-9. PubMed ID: 19816846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of Huntington's disease.
    Bobori C
    Adv Exp Med Biol; 2015; 822():59-65. PubMed ID: 25416977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of Huntington's disease.
    McFarland KN; Cha JH
    Handb Clin Neurol; 2011; 100():25-81. PubMed ID: 21496570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntington disease: pathogenesis and treatment.
    Dayalu P; Albin RL
    Neurol Clin; 2015 Feb; 33(1):101-14. PubMed ID: 25432725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
    Pouladi MA; Graham RK; Karasinska JM; Xie Y; Santos RD; Petersén A; Hayden MR
    Brain; 2009 Apr; 132(Pt 4):919-32. PubMed ID: 19224899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease: clinical presentation and treatment.
    Novak MJ; Tabrizi SJ
    Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Huntington chorea: genetics and biochemistry, diagnosis and therapy].
    Borbás T; Hegyesi H
    Acta Pharm Hung; 2002; 72(2):127-36. PubMed ID: 12498040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic modifiers of Huntington's disease.
    Gusella JF; MacDonald ME; Lee JM
    Mov Disord; 2014 Sep; 29(11):1359-65. PubMed ID: 25154728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mind the gap: models in multiple species needed for therapeutic development in Huntington's disease.
    Howland DS; Munoz-Sanjuan I
    Mov Disord; 2014 Sep; 29(11):1397-403. PubMed ID: 25155258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical neurogenetics: huntington disease.
    Bordelon YM
    Neurol Clin; 2013 Nov; 31(4):1085-94. PubMed ID: 24176425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease: pathomechanism and therapeutic perspectives.
    Gárdián G; Vécsei L
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1485-94. PubMed ID: 15480847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.